https://www.businesswire.com/news/home/20240513132852/en/Vesigen-Highlights-Key-in-vivo-and-Targeted-Tropism-Data-Advancements-for-Non-Viral-Delivery-Platform-at-2024-ASGCT-and-ARVO-Annual-Meetings
Vesigen Highlights Key in vivo and Targeted Tropism Data Advancements for Non-Viral Delivery...
Vesigen Therapeutics, Inc., a biotechnology company developing a novel non-viral delivery platform for gene editors, RNA, and protein-based therapeutics, rec...